REMIX THERAPEUTICS Trademark

Trademark Overview

On Monday, September 25, 2023, a trademark application was filed for REMIX THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the REMIX THERAPEUTICS trademark a serial number of 98195999. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, June 27, 2024. This trademark is owned by Remix Therapeutics Inc.. The REMIX THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for gene therapy and gene modulation; pharmaceutical compositions and therapeutic products in the nature of chemical and biological small molecules to degrade RNA, enhance expression, induce exon skipping, and rescue genetic lesions; pharmaceutical preparations, namely, RNA therapeutics for the treatment of genetic disorders, immune system related diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, cancer, neurological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, cardiological diseases and disorders, respiratory diseases and disorders, gastroenterological diseases and disorders, musculoskeletal diseases and disorders, ophthalmological diseases and disorders, and dermatological diseases and disorders

Medical and scientific research in the fields of genetics, genomics, gene modulation and genetic engineering; DNA and RNA analysis and sequencing services for scientific and research purposes; research, development and consultancy in the field of genomics and gene modulation; testing, inspection, research, and development of pharmaceutical preparations for gene modulation; development of pharmaceutical preparations for use in gene modulation; laboratory research in the fields of genetics, gene modulation, drug development
remix therapeutics

General Information

Serial Number98195999
Word MarkREMIX THERAPEUTICS
Filing DateMonday, September 25, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, June 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Description of MarkThe mark consists of design of sound waves in shades of blue and green preceding the literal elements REMIX and THERAPEUTICS with REMIX appearing above THERAPEUTICS.
Goods and ServicesPharmaceutical preparations for gene therapy and gene modulation; pharmaceutical compositions and therapeutic products in the nature of chemical and biological small molecules to degrade RNA, enhance expression, induce exon skipping, and rescue genetic lesions; pharmaceutical preparations, namely, RNA therapeutics for the treatment of genetic disorders, immune system related diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, cancer, neurological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, cardiological diseases and disorders, respiratory diseases and disorders, gastroenterological diseases and disorders, musculoskeletal diseases and disorders, ophthalmological diseases and disorders, and dermatological diseases and disorders
Indication of Colors claimedThe color(s) blue and green is/are claimed as a feature of the mark.
Goods and ServicesMedical and scientific research in the fields of genetics, genomics, gene modulation and genetic engineering; DNA and RNA analysis and sequencing services for scientific and research purposes; research, development and consultancy in the field of genomics and gene modulation; testing, inspection, research, and development of pharmaceutical preparations for gene modulation; development of pharmaceutical preparations for use in gene modulation; laboratory research in the fields of genetics, gene modulation, drug development

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 10, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, June 26, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRemix Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Friday, May 17, 2024NON-FINAL ACTION WRITTEN
Friday, May 17, 2024NON-FINAL ACTION E-MAILED
Friday, May 17, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 26, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 26, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 26, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 27, 2024NON-FINAL ACTION E-MAILED
Thursday, June 27, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 27, 2024NON-FINAL ACTION WRITTEN
Thursday, May 16, 2024ASSIGNED TO EXAMINER
Tuesday, October 10, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 11, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED

Related Keywords

therapeutics remix disorders diseases gene modulation research pharmaceutical development preparations genetic fields